BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Diferuloylmethane {Curcumin} - Pseudomonas aeruginosa N002 |
👶
In-Vitro Antibacterial Activity of Curcumin-Loaded Nanofibers Based on Hyaluronic Acid against Multidrug-Resistant ESKAPE Pathogens. Pharmaceutics (Pharmaceutics ) Vol: 14 Issue 6 Pages: Pub: 2022 May 31 Epub: 2022 May 31 Authors Snetkov P , Rogacheva E , Kremleva A , Morozkina S , Uspenskaya M , Kraeva L , Html Article Publication |
| Diferuloylmethane {Curcumin} - Pseudomonas aeruginosa N002 |
👶
Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations with Plant-Derived Compounds against P. aeruginosa Biofilms and Their Effects on the Metabolomic Profile of P. aeruginosa Biofilms. Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 10 Issue 4 Pages: Pub: 2021 Apr 9 Epub: 2021 Apr 9 Authors Kart D , Reçber T , Nemutlu E , Sagiroglu M , Html Article Publication |
| Diferuloylmethane {Curcumin} - Pseudomonas aeruginosa N002 |
👶
Curcumin, a Natural Antimicrobial Agent with Strain-Specific Activity. Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 13 Issue 7 Pages: Pub: 2020 Jul 16 Epub: 2020 Jul 16 Authors Adamczak A , Ozarowski M , Karpinski TM , Html Article Publication |
| Diferuloylmethane {Curcumin} - Pseudomonas aeruginosa N002 |
👶
Investigating antibacterial and anti-inflammatory properties of synthetic curcuminoids. Frontiers in medicine (Front Med (Lausanne) ) Vol: 11 Issue Pages: 1478122 Pub: 2024 Epub: 2024 Oct 29 Authors Veselá K , Kejík Z , Abramenko N , Kaplánek R , Jakubek M , Petrlova J , Html Article Publication |
| Diferuloylmethane {Curcumin} - Pseudomonas aeruginosa N002 |
👶
Antibiotic-Potentiating Effect of Some Bioactive Natural Products against Planktonic Cells, Biofilms, and Virulence Factors of Pseudomonas aeruginosa. BioMed research international (Biomed Res Int ) Vol: 2023 Issue Pages: 9410609 Pub: 2023 Epub: 2023 Aug 23 Authors Chimi LY , Bisso BN , Njateng GSS , Dzoyem JP , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
